Literature DB >> 19555872

Hypertension and cognitive function.

Thomas Olabode Obisesan1.   

Abstract

Cumulative evidence implicates hypertension in the pathogenesis of Alzheimer disease. Although it may not presently be possible to completely differentiate the effects of treatment and control of hypertension itself from those of the medication used to achieve such treatment goals, efforts directed at the treatment and control of hypertension can have significant public health impact.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555872      PMCID: PMC3160824          DOI: 10.1016/j.cger.2009.03.002

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  136 in total

1.  Association between blood pressure and cognitive function in a biracial community population of older persons.

Authors:  Martha Clare Morris; Paul A Scherr; Liesi E Hebert; David A Bennett; Robert S Wilson; Robert J Glynn; Denis A Evans
Journal:  Neuroepidemiology       Date:  2002 May-Jun       Impact factor: 3.282

2.  Arterial stiffness and the development of hypertension. The ARIC study.

Authors:  D Liao; D K Arnett; H A Tyroler; W A Riley; L E Chambless; M Szklo; G Heiss
Journal:  Hypertension       Date:  1999-08       Impact factor: 10.190

3.  Fiscal implications of population ageing.

Authors:  P Johnson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-12-29       Impact factor: 6.237

4.  Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging.

Authors:  C J Maxwell; D B Hogan; E M Ebly
Journal:  CMAJ       Date:  1999-09-07       Impact factor: 8.262

5.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

6.  The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults.

Authors:  S R Heckbert; W T Longstreth; B M Psaty; K E Murros; N L Smith; A B Newman; J D Williamson; C Bernick; C D Furberg
Journal:  J Am Geriatr Soc       Date:  1997-12       Impact factor: 5.562

7.  Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex.

Authors:  W J Lukiw; N G Bazan
Journal:  J Neurosci Res       Date:  1997-12-15       Impact factor: 4.164

8.  Tumor necrosis factor-alpha promotes sustained cyclooxygenase-2 expression: attenuation by dexamethasone and NSAIDs.

Authors:  D J Perkins; D A Kniss
Journal:  Prostaglandins       Date:  1997-10

9.  Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging.

Authors:  S Yasar; M Corrada; R Brookmeyer; C Kawas
Journal:  Neurobiol Aging       Date:  2005-02       Impact factor: 4.673

10.  Relationship between cognitive function and regional cerebral blood flow in Alzheimer's disease.

Authors:  Yo Ushijima; C Okuyama; S Mori; T Nakamura; T Kubota; T Nishimura
Journal:  Nucl Med Commun       Date:  2002-08       Impact factor: 1.690

View more
  25 in total

Review 1.  Potential predictors of hippocampal atrophy in Alzheimer's disease.

Authors:  Vikas Dhikav; Kuljeet Anand
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

2.  Two-kidney one-clip is a pertinent approach to integrate arterial hypertension in animal models of stroke: Serial magnetic resonance imaging studies of brain lesions before and during cerebral ischemia.

Authors:  Benjamin Ménard; Laurent Chazalviel; Simon Roussel; Myriam Bernaudin; Omar Touzani
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

3.  Independent and interactive impacts of hypertension and diabetes mellitus on verbal memory: A coordinated analysis of longitudinal data from England, Sweden, and the United States.

Authors:  Amanda Kelly; Matthew Calamia; Andrey Koval; Graciela Muniz Terrera; Andrea M Piccinin; Sean Clouston; Linda B Hassing; David A Bennett; Boo Johansson; Scott M Hofer
Journal:  Psychol Aging       Date:  2016-02-25

Review 4.  Antihypertensive Therapies and Cognitive Function: a Review.

Authors:  Nisharahmed Kherada; Todd Heimowitz; Clive Rosendorff
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

5.  Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats.

Authors:  Ruby Goel; Shahnawaz Ali Bhat; Kashif Hanif; Chandishwar Nath; Rakesh Shukla
Journal:  Mol Neurobiol       Date:  2017-02-18       Impact factor: 5.590

Review 6.  The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment.

Authors:  Osigbemhe Iyalomhe; Sabina Swierczek; Ngozi Enwerem; Yuanxiu Chen; Monica O Adedeji; Joanne Allard; Oyonumo Ntekim; Sheree Johnson; Kakra Hughes; Philip Kurian; Thomas O Obisesan
Journal:  Cell Mol Neurobiol       Date:  2016-11-17       Impact factor: 5.046

Review 7.  Clinical Trials of Blood Pressure Lowering and Antihypertensive Medication: Is Cognitive Measurement State-of-the-Art?

Authors:  Merrill F Elias; Rachael V Torres; Adam Davey
Journal:  Am J Hypertens       Date:  2018-05-07       Impact factor: 2.689

8.  Comparison of processing speed, balance, mobility and fear of falling between hypertensive and normotensive individuals.

Authors:  Isılay Ozaldemir; Gozde Iyigun; Mehtap Malkoc
Journal:  Braz J Phys Ther       Date:  2019-09-23       Impact factor: 3.377

9.  Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Julius S Ngwa; Thomas V Fungwe; Oyonumo Ntekim; Joanne S Allard; Sheree M Johnson; Chimene Castor; Lennox Graham; Sheeba Nadarajah; Richard F Gillum; Thomas O Obisesan
Journal:  Dement Geriatr Cogn Disord       Date:  2018-04-25       Impact factor: 2.959

Review 10.  Modifiable comorbidities and disability in multiple sclerosis.

Authors:  Shannon Overs; Christina M Hughes; Jodie K Haselkorn; Aaron P Turner
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.